Clinical Manifestation of AGE-RAGE Axis in Neurodegenerative and Cognitive Impairment Disorders
Drug Research · 01.07.2023 · 73 (06) · 309-317
DOI: 10.1055/a-2004-3591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 01.07.2023. Verfasst von Sabreena Naz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
The receptor of Advanced Glycation Endproducts (RAGE) and Advanced Glycation Endproducts (AGE) have multiple functions in our body and their restraint are being observed in neurodegenerative and memory impairment disorders. The review of different pathways allows an understanding of the probable mechanism of neurodegeneration and memory impairment involving RAGE and AGE. Commonly we observe AGE accumulation in neural cells and tissues but the extent of accumulation increases with the presence of memory impairment disorder. The presence of AGEs can also be seen in morbid accumulation, pathological structures in the form of amyloid clots, and nervous fibrillary tangles in Alzheimer’s Disease (AD) and memory impairment disease. Many neuropathological and biochemical aspects of AD are explained by AGEs, including widespread protein crosslinking, glial activation of oxidative stress, and neuronal cell death. Oxidative stress is due to different reasons and glycation end products set in motion and form or define various actions which are normally due to AGE changes in a pathogenic cascade. By regulating the transit of ß-amyloid in and out of the brain or altering inflammatory pathways, AGE and it’s ensnare receptor such as soluble RAGE may function as blockage or shield AD development. RAGE activates the transcription-controlling factor Necrosis Factor (NF-κB) and increases the protraction of cytokines, like a higher number of Tumor Necrosis Factor (TNF-α) and Interleukin (IL-I) by inducing several signal transduction cascades. Furthermore, binding to RAGE can pro-activate reactive oxygen species (ROS), which is popularly known to cause neuronal death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, India.
- Department of Pharmacy, Hygia Institute of Pharmaceutical Education and Research, Lucknow, India.
- Department of Bioengineering, Faculty of Engineering, Integral University, Lucknow, India.
Zitieren
APA
Naz, S., Mahmood, T., Gupta, R., Siddiqui, M. H., Ahsan, F., Ansari, V. A., Shamim, A., & Rizvi, A. A. (2023). Clinical Manifestation of AGE-RAGE Axis in Neurodegenerative and Cognitive Impairment Disorders. Drug Research, 73(06), 309-317. https://doi.org/10.1055/a-2004-3591
Vancouver
Naz S, Mahmood T, Gupta R, Siddiqui MH, Ahsan F, Ansari VA, et al. Clinical Manifestation of AGE-RAGE Axis in Neurodegenerative and Cognitive Impairment Disorders. Drug Research. 2023;73(06):309-317. doi:10.1055/a-2004-3591
BibTeX
@article{Naz2023,
author = {Naz, Sabreena and Mahmood, Tarique and Gupta, Ramesh and Siddiqui, Mohammed Haris and Ahsan, Farogh and Ansari, Vaseem Ahamad and Shamim, Arshiya and Rizvi, Ali Abbas},
title = {Clinical Manifestation of AGE-RAGE Axis in Neurodegenerative and Cognitive Impairment Disorders},
journal = {Drug Research},
year = {2023},
volume = {73},
number = {06},
pages = {309--317},
doi = {10.1055/a-2004-3591}
}
EUVIMED